Yesterday TapImmune Inc. (OTCMKTS:TPIV) published a new PR announcing the successful transfer of the Mayo Clinic Investigational New Drug Application as part of the recently completed licensing agreement. This brings the company one step closer...
Yesterday, TapImmune Inc. (OTCMKTS:TPIV) crashed as abruptly as it had spiked in the previous session, and the reasons for that remain as mysterious as those of its ascent. Just two days ago, the general...
Last Friday saw TapImmune Inc. (OTCMKTS:TPIV) rise 9.80% up the charts, in spite of the apparent lack of developments around the company lately. TPIV hasn’t had any new press releases since the announcement of...
TapImmune Inc. (OTCMKTS:TPIV) managed to add 8.74% to its market value yesterday, after announcing that it has secured some non-dilutive funding, but judging by today’s red opening, it may not be able to keep...
TapImmune Inc. (OTCMKTS:TPIV) had a nice little change of pace when it announced that it has acquired further funding, but unfortunately for its supporters, said turn of events didn’t last very long. Friday saw...
TapImmune Inc. (OTCMKTS:TPIV) managed to add 18.80% to its market value yesterday, after declaring that it has secured another million dollars worth of funding. The company’s latest 8-K hit the web before the session’s...
When it’s raining over at TapImmune Inc. (OTCMKTS:TPIV), it seems it’s pouring. In yesterday’s session the stock slid in double digits once again. TPIV had slipped down to $0.55 per share by the closing...
During yesterday’s trading the stock of TapImmune Inc. (OTCMKTS:TPIV) suffered another severe correction and closed the session at $0.641 for a loss of 14.5%. After hitting a high of $1.71 on June 23 the...
On June 23 the stock of TapImmune Inc. (OTCMKTS:TPIV) logged its new 52-week high of $1.71 per share. Since then however the ticker has been able to register only 6 sessions ending in the green....
It seems the cheering started a little too soon with TapImmune Inc. (OTCMKTS:TPIV). Shareholders were ecstatic to see the stock climb from a modest couple of dimes per share to over $1.50 within under...